Gunnar Wahlberg
Corporate Officer/Principal presso IDL BIOTECH AB
Posizioni attive di Gunnar Wahlberg
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IDL BIOTECH AB | Corporate Officer/Principal | - | - |
| Amministratore Delegato | - | - | |
| Vendite & Marketing | 01/01/2019 | - | |
| AROCELL AB | Vendite & Marketing | 01/01/2021 | - |
Storia della carriera di Gunnar Wahlberg
Statistiche
Distribuzione geografica
| Svezia | 3 |
Posizioni
| Sales & Marketing | 2 |
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AROCELL AB | Health Technology |
| Aziende private | 1 |
|---|---|
IDL Biotech AB
 IDL Biotech AB Medical SpecialtiesHealth Technology IDL Biotech AB engages in the development, production and marketing of in vitro diagnostic tests for the healthcare sector. The firm is active in the fields of Oncology and Bacteriology, manufacturing various tumor markers and a rapid Salmonella Typhoid test. Its products include TPS, TPAcyk, UBC, Monototal, and Tubex. The company was founded in 1988 and is headquartered in Bromma, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Gunnar Wahlberg
- Esperienza
